Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes antibodies, antibody-drug conjugates and other protein-based therapeutics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases.

View all →   RSSRecent Releases
Jun 16, 2017 Celldex Therapeutics Announces Additions to the Board of Directors and Senior Management Team
Jun 6, 2017 Celldex Therapeutics to Participate in the Jefferies 2017 Global Healthcare Conference
More →Upcoming Events
Details on upcoming events are not yet available.
Featured Financial Reports
Filing Date Title Type Size
May 9, 2017 Form 10-Q View HTML View PDF 333.5 KB Add to Briefcase
Mar 14, 2017 Form 10-K View HTML View PDF 809.4 KB Add to Briefcase
Add to Briefcase = add file to Briefcase